Author Details

Жернакова, Юлия Валерьевна

Issue Section Title File
Vol 10, No 2 (2013) Articles Use of diuretics in hypertensive patients with metabolic disturbances
Vol 10, No 3 (2013) Articles Primenenie diuretikov u bol'nykh arterial'noy gipertoniey s metabolicheskimi narusheniyami
Vol 10, No 4 (2013) Articles The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District
Vol 10, No 3 (2013) Articles Izuchenie kognitivnykh funktsiy mozga u bol'nykh arterial'noy gipertoniey s nalichiem ili otsutstviem metabolicheskogo sindroma
Vol 10, No 4 (2013) Articles Coagulogic risk factors of heart disease in the adult population of Tomsk
Vol 11, No 1 (2014) Articles Hypertension treatment features in perimenopausal women PDF
(Rus)
Vol 11, No 1 (2014) Articles Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components PDF
(Rus)
Vol 11, No 2 (2014) Articles Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders PDF
(Rus)
Vol 11, No 4 (2014) Articles The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk PDF
(Rus)
Vol 11, No 4 (2014) Articles The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF PDF
(Rus)
Vol 11, No 4 (2014) Articles The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders PDF
(Rus)
Vol 12, No 2 (2015) Articles Calcium channel blockers: more than 50 years on guard of health PDF
(Rus)
Vol 12, No 1 (2015) Articles The role of beta-blockers in the treatment of arterial hypertension: what do we know today PDF
(Rus)
Vol 12, No 3 (2015) Articles Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension PDF
(Rus)
Vol 12, No 3 (2015) Articles The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study) PDF
(Rus)
Vol 12, No 1 (2015) Articles Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach PDF
(Rus)
Vol 14, No 3 (2017) Articles The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders PDF
(Rus)
Vol 15, No 1 (2018) Articles The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results PDF
(Rus)
Vol 15, No 3 (2018) Articles Obesity as a predictor for cardiovascular disease development: role of localized fat depot PDF
(Rus)
Vol 15, No 4 (2018) Articles Polypill" conception in modern cardiology PDF
(Rus)
Vol 15, No 4 (2018) Articles Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients PDF
(Rus)
Vol 15, No 4 (2018) Articles Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity PDF
(Rus)
Vol 16, No 4 (2019) Articles Consensus on patients with hyperuricemia and high cardiovascular risk treatment PDF
(Rus)
Vol 16, No 3 (2019) Articles The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus PDF
(Rus)
Vol 16, No 2 (2019) Articles Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity PDF
(Rus)
Vol 16, No 4 (2019) Articles Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity PDF
(Rus)
Vol 17, No 2 (2020) Review COVID-19: a patient with cardiovascular disease at high risk PDF
(Rus)
Vol 17, No 3 (2020) Expert opinion Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19 PDF
(Rus)
Vol 17, No 3 (2020) Guidelines Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease PDF
(Rus)
Vol 17, No 4 (2020) Articles Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity PDF
(Rus)
Vol 17, No 4 (2020) Articles Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus PDF
(Rus)
Vol 17, No 4 (2020) Articles Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity PDF
(Rus)
Vol 18, No 3 (2021) Expert opinion Management of patients with arterial hypertension and atrial fibrillation PDF
(Rus)
Vol 18, No 3 (2021) Original Article Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders PDF
(Rus)
Vol 18, No 4 (2021) Case Report Possibilities of a new glucagon-like peptide-1 receptor agonist Semaglutide in improving left ventricular diastolic function in a patient with arterial hypertension and type 2 diabetes mellitu PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies